22 May 2013
Keywords: cephalon, buy, salmedix, 160m, biotechnology, firm, says
Article | 23 May 2005
US biotechnology firm Cephalon says it has signed a definitive merger agreement under which it will acquire all of the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 May 2005
© 2013 thepharmaletter.com